NM_005198.5:c.818+40T>C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005198.5(CHKB):​c.818+40T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 1,612,786 control chromosomes in the GnomAD database, including 177,190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 12823 hom., cov: 33)
Exomes 𝑓: 0.47 ( 164367 hom. )

Consequence

CHKB
NM_005198.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.183
Variant links:
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 22-50580150-A-G is Benign according to our data. Variant chr22-50580150-A-G is described in ClinVar as [Benign]. Clinvar id is 1294337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-50580150-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.477 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHKBNM_005198.5 linkc.818+40T>C intron_variant Intron 7 of 10 ENST00000406938.3 NP_005189.2 Q9Y259-1A0A024R4X4
CHKB-CPT1BNR_027928.2 linkn.1036+40T>C intron_variant Intron 7 of 29

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHKBENST00000406938.3 linkc.818+40T>C intron_variant Intron 7 of 10 1 NM_005198.5 ENSP00000384400.3 Q9Y259-1

Frequencies

GnomAD3 genomes
AF:
0.383
AC:
58230
AN:
152062
Hom.:
12828
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.532
Gnomad AMR
AF:
0.434
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.470
Gnomad SAS
AF:
0.363
Gnomad FIN
AF:
0.527
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.482
Gnomad OTH
AF:
0.392
GnomAD3 exomes
AF:
0.444
AC:
110870
AN:
249564
Hom.:
25754
AF XY:
0.445
AC XY:
60124
AN XY:
135110
show subpopulations
Gnomad AFR exome
AF:
0.139
Gnomad AMR exome
AF:
0.464
Gnomad ASJ exome
AF:
0.450
Gnomad EAS exome
AF:
0.466
Gnomad SAS exome
AF:
0.362
Gnomad FIN exome
AF:
0.529
Gnomad NFE exome
AF:
0.484
Gnomad OTH exome
AF:
0.452
GnomAD4 exome
AF:
0.470
AC:
686023
AN:
1460604
Hom.:
164367
Cov.:
35
AF XY:
0.467
AC XY:
339141
AN XY:
726632
show subpopulations
Gnomad4 AFR exome
AF:
0.135
Gnomad4 AMR exome
AF:
0.463
Gnomad4 ASJ exome
AF:
0.442
Gnomad4 EAS exome
AF:
0.474
Gnomad4 SAS exome
AF:
0.368
Gnomad4 FIN exome
AF:
0.521
Gnomad4 NFE exome
AF:
0.488
Gnomad4 OTH exome
AF:
0.441
GnomAD4 genome
AF:
0.383
AC:
58231
AN:
152182
Hom.:
12823
Cov.:
33
AF XY:
0.386
AC XY:
28702
AN XY:
74392
show subpopulations
Gnomad4 AFR
AF:
0.148
Gnomad4 AMR
AF:
0.434
Gnomad4 ASJ
AF:
0.441
Gnomad4 EAS
AF:
0.470
Gnomad4 SAS
AF:
0.362
Gnomad4 FIN
AF:
0.527
Gnomad4 NFE
AF:
0.482
Gnomad4 OTH
AF:
0.389
Alfa
AF:
0.460
Hom.:
20805
Bravo
AF:
0.372
Asia WGS
AF:
0.368
AC:
1280
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jun 23, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.1
DANN
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140514; hg19: chr22-51018579; COSMIC: COSV56414928; COSMIC: COSV56414928; API